Policy Matters
Cancer screenings and clinical trials have been seriously disrupted by the pandemic.
by Nicholas Warren, PhD
Forward Look
Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.
by Kris Conner
Get Involved
Students Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients.
by Bradley Jones
Survivor Profile
Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.
Health care providers and communities are making strides toward ensuring equity in cancer treatment.
by Marci A. Landsmann
Can discussion of health inequities lead to actionable change?
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond.
by Kevin McLaughlin
Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.
by Jen Tota McGivney
Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience.
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
While melanoma is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly.
Learning Medicare’s ABCDs
donate to the AACR